Capecitabine-induced cerebellar toxicity

Clinical Colorectal Cancer

Volumn 6, Issue 1, 2006, Pages 70-71

  Renouf, Daniel ^a   Gill, Sharlene ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

5 fluorouracil; Chemotherapy; Neurotoxicity

Indexed keywords

CAPECITABINE; RABEPRAZOLE;

AGED; ARTICLE; BALANCE IMPAIRMENT; CANCER ADJUVANT THERAPY; CANCER STAGING; CASE REPORT; CEREBELLAR ATAXIA; COLON ADENOCARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HAND FOOT SYNDROME; HEMICOLECTOMY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; STOMATITIS;

EID: 33745920740     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2006.n.024     Document Type: Article

References (8)

1. Couch LS, Groteluschen DL, Stewart JA, et al. Capecitabine-related neurotoxicity presenting as trismus. Clin Colorectal Cancer 2003; 3:121-123.
2. Schuller J, Cassidy J, Dumont E, et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 2000; 45:291-297.
3. Pirzada NA, Imran IA, Dafer RM. Fluorouracil-induced neurotoxicity. The Ann Pharmacother 2000; 34:35-38.
4. Niemann B, Rochlitz C, Herrmann R, et al. Toxic encephalopathy induced by capecitabine. Oncology 2004; 66:331-335.
5. Milano G, Etienne MC, Pierrefite V, et al. Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity. British J Cancer 1999; 79:627-630.
6. Diasio RB, Beavers TL, Carpenter JT. Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil induced toxicity. J Clin Invest 1988; 81:47-51.
7. Boileau G, Piro AJ, Lahiri SR, et al. Cerebellar ataxia during 5-fluorouracil therapy. Cancer Chemother Rep 1971; 55:595-598.
8. Videnovic A, Chua-Adajar R, Baddi L, et al. Capecitabine-induced multifocal leukoencephalopathy: a report of five cases. Neurology 2005; 65:1792-1794.